BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Life Sciences British Columbia - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Life Sciences British Columbia
X-ORIGINAL-URL:https://lifesciencesbc.ca
X-WR-CALDESC:Events for Life Sciences British Columbia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20170312T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20171105T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20180311T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20181104T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190416
DTEND;VALUE=DATE:20190417
DTSTAMP:20260404T110632
CREATED:20210406T220910Z
LAST-MODIFIED:20210913T180858Z
UID:24168-1555372800-1555459199@lifesciencesbc.ca
SUMMARY:Seminar: Taking Your Patent Portfolio Global
DESCRIPTION:On Tuesday\, April 16\, 2019\, LifeSciences BC held a seminar providing tips and strategies for effectively taking your company’s patent portfolio global.  Lawyers from Oyen Wiggs provided a brief overview of the patent filing process\, tips for the effective use of provisional patent applications\, and an overview of the Patent Cooperation Treaty (PCT) filing process.  Important considerations for select countries where Canadian companies frequently pursue patent protection were also briefly reviewed. \nCynthia Shippam-Brett\, Industrial Technical Advisor\, National Research Council Canada shared her perspectives on issues faced by companies taking their patent portfolios global\, and Graeme Herring\, V.P. of Intellectual Property Strategy at Terramera Inc.\, shared an in-house perspective on dealing with the challenges of developing and managing a global patent portfolio. \nThis seminar was of interest to scientists and business executives who are involved with IP on a strategic level\, including those with an interest in learning more about how the global patent system works and strategies for navigating that system successfully.  A networking reception with refreshments followed the seminar. \n\nSpeakers:\n\n\nJayde Wood\, Associate\, Oyen Wiggs\nStephanie Melnychuk\, Associate\, Oyen Wiggs\nJennifer Marles\, Partner\, Oyen Wiggs\nCynthia Shippam-Brett\, Industrial Technical Advisor\, National Research Council Canada\nGraeme Herring\, V.P. of Intellectual Property Strategy at Terramera Inc. (LifeSciences Company of the Year)\n\n\nThank you to our sponsor:
URL:https://lifesciencesbc.ca/event/seminar-taking-your-patent-portfolio-global/
CATEGORIES:2019
ATTACH;FMTTYPE=image/jpeg:https://lifesciencesbc.ca/wp-content/uploads/2021/04/patentportfolio2019.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190404
DTEND;VALUE=DATE:20190405
DTSTAMP:20260404T110632
CREATED:20210406T221221Z
LAST-MODIFIED:20210902T182319Z
UID:24171-1554336000-1554422399@lifesciencesbc.ca
SUMMARY:21st Annual LifeSciences BC Awards\, presented by FARRIS
DESCRIPTION:On Thursday\, April 4\, 2019\, LifeSciences BC held the 21st Annual LifeSciences BC Awards\, presented by: \n \nThe 21st Annual LifeSciences BC Award Winners:  \n\nGenome BC Award for Scientific Excellence – Dr. Caroline Cameron\nMichael Smith Foundation for Health Research – Aubrey J. Tingle Prize – Dr. Jerilynn Prior\nDeal of the Year – Anandia Laboratories \nStrategic LifeSciences Partner of the Year Award – Creative Destruction Lab (CDL) – West\nGrowth Stage Life Sciences Company of the Year – Aspect Biosystems\nMilton Wong Award for Leadership – Natalie Dakers\nLifeSciences Company of the Year – Terramera Inc.\nDr. Don Rix Award for Lifetime Achievement – Dr. Marco Marra\n\nThe 21st Annual LifeSciences BC Awards\, presented by FARRIS on April 4\, 2019\, was an opportunity to celebrate our community’s many achievements\, small wins and big victories\, with our peers\, family and friends. This event was our moment to recognize and honour the efforts of all those who have invested their lives’ work in mastering successful health outcomes. \nB.C. has found its place on the international life sciences stage and is recognized in Canada and beyond for its significant accomplishments in medical technology\, biopharmaceuticals\, health delivery systems\, and medical research & development initiatives – the envy of many. We have reached beyond our borders to impact patient health and connect to the world at large\, while ensuring the life science sector here\, at home\, remains vibrant and sustainable. \nWe are fortunate to have a life science ecosystem that bridges academia and a thriving research & development bionetworks\, including world-class healthcare facilities\, distinguished health & medical foundations\, and renowned centres of excellence that are supportive of translation and commercializing innovation in healthcare.
URL:https://lifesciencesbc.ca/event/21st-annual-lifesciences-bc-awards-presented-by-farris/
CATEGORIES:2019
ATTACH;FMTTYPE=image/png:https://lifesciencesbc.ca/wp-content/uploads/2021/04/farris2019.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190306
DTEND;VALUE=DATE:20190307
DTSTAMP:20260404T110632
CREATED:20210406T221359Z
LAST-MODIFIED:20210902T182028Z
UID:24174-1551830400-1551916799@lifesciencesbc.ca
SUMMARY:Showcase Series: Victoria
DESCRIPTION:[vc_row][vc_column][vc_column_text]\nOn Wednesday\, March 6\, 2019\, LifeSciences BC offered a unique opportunity to learn more about LifeSciences BC along with the cutting-edge research and development being done in the Victoria area. The event also provided the opportunity to network with a wide range of guests from the political\, business and academic worlds. \nEmcee: Scott Phillips\, Board Member\, LifeSciences BC & CEO and Founder\, StarFish Medical \n\nAnnounced Speakers:\n\n\n\nAndrew Booth\, Chief Commercial Officer\, STEMCELL Technologies\nDr. Lisa Kalynchuk\, Associate Vice-President of Research\, University of Victoria\nDr. Christine Lee\, Medical Microbiologist and Clinician Researcher\, Island Health\nDr. Stephanie Willerth\, Associate Professor\, Department of Mechanical Engineering & Division of Medical Sciences\, University of Victoria\n\n\nThank you to our sponsors: \nEvent Sponsors: Innovate BC & STEMCELL Technologies \n          \n  \nSpeaker Sponsor: Michael Smith Foundation for Health Research \n \n  \nEvent Supporter: Research Partnerships and Knowledge Mobilization\, University of Victoria \n[/vc_column_text][/vc_column][/vc_row]
URL:https://lifesciencesbc.ca/event/showcase-series-victoria-2/
CATEGORIES:2019
ATTACH;FMTTYPE=image/png:https://lifesciencesbc.ca/wp-content/uploads/2021/04/victoria2019.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190301
DTEND;VALUE=DATE:20190302
DTSTAMP:20260404T110632
CREATED:20190301T080049Z
LAST-MODIFIED:20210913T180716Z
UID:718-1551398400-1551484799@lifesciencesbc.ca
SUMMARY:LifeSciences BC Blakes Breakfast Speaking Event: Cell and Gene Therapy
DESCRIPTION:On Friday\, March 1\, 2019\, LifeSciences BC held the spring Blakes Breakfast Speaking Event.\n \nThe Blakes Breakfast Speaking Series is our longest-standing event series and one of our most popular. Held four times a year\, these breakfasts include presentations by local\, national and multinational life science companies and typically attract a cross-section of approximately 40 of our life sciences community members. The Breakfast Speaking Series is proudly presented by Blake\, Cassels & Graydon LLP. \n  \nTheme: “Cell and Gene Therapy – Discovery to Translational Perspectives” \n  \nAnnounced Speakers: \n\nDr. Lazar Bojic\, Senior Director\, Corporate Development\nenGene USA\nAlexander Graves\, President and CEO\nSymvivo\nDr. Elizabeth Simpson\, Professor\nDepartment of Medical Genetics\, The University of British Columbia\nDr. Chris Springate\, CEO\nARC Medical Devices Inc.
URL:https://lifesciencesbc.ca/event/lifesciences-bc-blakes-breakfast-speaking-event-cell-and-gene-therapy/
LOCATION:Terminal City Club\, Vancouver\, Canada
CATEGORIES:2019
ATTACH;FMTTYPE=image/png:https://lifesciencesbc.ca/wp-content/uploads/2019/03/blakesmar2019.png
ORGANIZER;CN="Life Sciences BC":MAILTO:events@lifesciencesbc.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190228
DTEND;VALUE=DATE:20190301
DTSTAMP:20260404T110632
CREATED:20210406T221800Z
LAST-MODIFIED:20210913T180439Z
UID:24182-1551312000-1551398399@lifesciencesbc.ca
SUMMARY:21st Annual LifeSciences BC Awards\, presented by FARRIS - CALL FOR NOMINATIONS
DESCRIPTION:DEADLINE FOR NOMINATIONS \n5.00 PM (PT) FRIDAY\, FEBRUARY 8\, 2019
URL:https://lifesciencesbc.ca/event/21st-annual-lifesciences-bc-awards-presented-by-farris-call-for-nominations/
CATEGORIES:2019
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190228
DTEND;VALUE=DATE:20190301
DTSTAMP:20260404T110632
CREATED:20210406T221658Z
LAST-MODIFIED:20210913T180556Z
UID:24180-1551312000-1551398399@lifesciencesbc.ca
SUMMARY:LifeSciences BC and JLABS: The Future of Blockchain in Healthcare
DESCRIPTION:Have you ever needed to go to a walk-in clinic or emergency room\, and been frustrated when you need to run through your entire medical history with the doctor because they don’t have access to your files? With blockchain\, this is going to and has already started to change. \nBlockchain technology has the potential to transform healthcare by placing the patient at the center of the healthcare ecosystem. It has the ability to create a secure\, private\, global database that will lead to better patient care and stable\, protected personal medical information. Blockchain has the ability to shift precision medicine from a trial concept to common practice. \nOn Thursday\, February 28\, 2019\, JLABS and LifeSciences BC invited attendees to learn more about blockchain’s role in the healthcare sector\, and how it will (or will not) improve and change the patient experience. Through our presentation and panel discussion\, attendees saw real-world examples of use cases\, applications\, and heard a real discussion on if blockchain will really do everything we think. \nKeynote Speaker: \n\nKate Merton\, Head\, JLABS @ NYC\, Boston & JPOD @ Philadelphia\n\nOther Speakers included: \n\nDavid Houlding\, Principal Healthcare Lead\nMicrosoft\nVictoria Lemieux\, Associate Professor\nUniversity of British Columbia\nAndy Park\, Co-Founder\nCoral Health\n\nThe Future of Blockchain in Healthcare
URL:https://lifesciencesbc.ca/event/lifesciences-bc-and-jlabs-the-future-of-blockchain-in-healthcare/
CATEGORIES:2019
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190201
DTEND;VALUE=DATE:20190202
DTSTAMP:20260404T110632
CREATED:20210406T221852Z
LAST-MODIFIED:20210913T175718Z
UID:24184-1548979200-1549065599@lifesciencesbc.ca
SUMMARY:LifeSciences BC at the Vancouver Symphony Orchestra
DESCRIPTION:Maestro Bramwell Tovey conducts Bruckner & Debussy\n  \nOn Friday\, February 1\, and Saturday\, February 2\, 2019\, LifeSciences BC invited attendees for a special night at the Vancouver Symphony Orchestra\, as Maestro Bramwell Tovey made his return as VSO Music Director Emeritus after 18 extraordinary years as the longest-serving Music Director in the VSO’s century-long history. Tovey conducted a piece by the very first composer he commissioned as Music Director\, featuring the VSO’s former Principal Cello Ariel Barnes and harpist Heidi Krutzen. This concert also featured the towering sonic architecture of Bruckner’s Symphony No. 6. LSBC members were provided with a special offer on tickets to attend the Vancouver Symphony Orchestra. \nSpecial guest artists: Ariel Barnes\, former Principal Cello of the VSO & Harpist Heidi Krutzen
URL:https://lifesciencesbc.ca/event/lifesciences-bc-at-the-vancouver-symphony-orchestra/
CATEGORIES:2019
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190130
DTEND;VALUE=DATE:20190131
DTSTAMP:20260404T110632
CREATED:20190130T080003Z
LAST-MODIFIED:20210913T175503Z
UID:723-1548806400-1548892799@lifesciencesbc.ca
SUMMARY:Access to Innovation 2019 Conference
DESCRIPTION:[vc_row][vc_column][vc_column_text]\nOn Wednesday\, January 30\, 2019\, LifeSciences BC held the 4th annual ACCESS TO INNOVATION Conference at the Vancouver Convention Centre West. \nStakeholders included: Academia\, Health Institutions\, Government\, Centres of Innovation\, SMEs\, Multi-national Corporates\, Investors and Payers. \n  \nCheck out below what some of the attendees from the Access to Innovation 2018 conference had to say: \n\n\n\n\n\n\n\n\n\n\n\n\n 
URL:https://lifesciencesbc.ca/event/access-to-innovation-2019-conference/
LOCATION:Vancouver Convention Centre\, Vancouver\, Canada
CATEGORIES:2019
ATTACH;FMTTYPE=image/png:https://lifesciencesbc.ca/wp-content/uploads/2019/01/access2019.png
ORGANIZER;CN="Life Sciences BC":MAILTO:events@lifesciencesbc.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181206
DTEND;VALUE=DATE:20181207
DTSTAMP:20260404T110632
CREATED:20181207T080009Z
LAST-MODIFIED:20210902T235348Z
UID:565-1544054400-1544140799@lifesciencesbc.ca
SUMMARY:LifeSciences BC Holiday Social
DESCRIPTION:On Thursday\, December 6\, 2018\, LifeSciences BC held the LifeSciences BC Holiday Social event in St. Regis Bar and Grill’s private event room. This was an opportunity to meet with peers in the life sciences industry for a festive evening of networking and socializing.
URL:https://lifesciencesbc.ca/event/lifesciences-bc-holiday-social/
LOCATION:Regis Room in the St. Regis Bar & Grill\, Canada
CATEGORIES:2018
ATTACH;FMTTYPE=image/png:https://lifesciencesbc.ca/wp-content/uploads/2018/12/holidaysocial2018.png
ORGANIZER;CN="Life Sciences BC":MAILTO:events@lifesciencesbc.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181122
DTEND;VALUE=DATE:20181123
DTSTAMP:20260404T110632
CREATED:20181122T080021Z
LAST-MODIFIED:20210914T164151Z
UID:570-1542844800-1542931199@lifesciencesbc.ca
SUMMARY:LifeSciences BC Blakes Breakfast Speaking Event
DESCRIPTION:On Thursday\, November 22\, 2018\, LifeSciences BC held the fall Blakes Breakfast Speaking Event. \n \nTheme: “Post Cannabis Legalization Opportunities and Challenges” \nAnnounced Speakers: \n\nJamie Brown\, Vice Chairman & Managing Director\, CANACCORD Genuity\nDamian Kettlewell\, Chair\, Founder & CEO\, BlissCo Cannabis Corp\nChris Nyberg\, Associate\, Blakes LLP\nDan Sutton\, CEO\, Tantalus Labs\nChris Wagner\, CEO\, Emerald Health Therapeutics\n\nThe Blakes Breakfast Speaking Series is our longest-standing event series and one of our most popular. Held four times a year\, these breakfasts include presentations by local\, national and multinational life science companies and typically attract a cross-section of approximately 40 of our life sciences community members. The Breakfast Speaking Series is proudly presented by Blake\, Cassels & Graydon LLP.
URL:https://lifesciencesbc.ca/event/post-cannabis-legalization-opportunities-and-challenges/
LOCATION:Hyatt Regency Vancouver\, Canada
CATEGORIES:2018
ATTACH;FMTTYPE=image/png:https://lifesciencesbc.ca/wp-content/uploads/2018/11/blakesnov222018.png
ORGANIZER;CN="Life Sciences BC":MAILTO:events@lifesciencesbc.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181120
DTEND;VALUE=DATE:20181121
DTSTAMP:20260404T110632
CREATED:20181120T080008Z
LAST-MODIFIED:20210914T164332Z
UID:628-1542672000-1542758399@lifesciencesbc.ca
SUMMARY:LifeSciences BC Showcase Series: Kelowna
DESCRIPTION:On Tuesday\, November 20\, 2019\, LifeSciences BC presented a unique opportunity to learn more about LifeSciences BC along with the cutting-edge research and development being done in the Kelowna area. The event was a networking opportunity for a wide range of guests from the political\, business and academic worlds. \nSpeakers: \nAndrew Booth\, Chief Commercial Officer\, STEMCELL Technologies \nLynda Brown-Ganzert\, Founder & CEO\, Curatio\nDr. Lesley Esford\, President & CEO of LifeSciences BC \nDr. Kathleen Martin Ginis\, Professor\, UBC Okanagan & Founding Director\, SCI Action Canada \nDr. Jonathan Little\, Associate Professor\, UBC Okanagan & Michael Smith Foundation for Health Research 2017 Scholar \nThank you to our sponsors! \nEvent Sponsors: Innovate BC & STEMCELL Technologies \nSpeaker Sponsor: Michael Smith Foundation for Health Research \nEvent Supporter: UBC Okanagan
URL:https://lifesciencesbc.ca/event/lifesciences-bc-showcase-series-kelowna-5/
LOCATION:Kelowna\, Canada
CATEGORIES:2018
ATTACH;FMTTYPE=image/png:https://lifesciencesbc.ca/wp-content/uploads/2018/11/kelowna2018.png
ORGANIZER;CN="Life Sciences BC":MAILTO:events@lifesciencesbc.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181116
DTEND;VALUE=DATE:20181117
DTSTAMP:20260404T110632
CREATED:20181116T080051Z
LAST-MODIFIED:20210902T234502Z
UID:632-1542326400-1542412799@lifesciencesbc.ca
SUMMARY:NRC’s Human Health Therapeutics Programs Recharge
DESCRIPTION:On Friday\, November 16\, 2018\, LifeSciences BC held the NRC’s Human Health Therapeutics Programs Recharge. \n  \nThe National Research Council Canada Human Health Therapeutics (NRC-HHT) programs have recently been refreshed to incorporate a new NRC collaboration model that includes grants and contributions. \nRecently announced “NRC Health Challenge Program” is being scoped around the theme of engineered cell- and gene-based therapy development and delivery\, in broad consultations with Canadian academia\, hospitals and business communities. The NRC Health Challenge Program’s three main thrusts are: 1) next-generation chimeric antigen receptors (CARs); 2) induced pluripotent stem cell (iPSC) technologies; and 3) in vivo genome editing. \nAcademia and industry were encouraged to attend this event to provide NRC with their input into the program development and discuss future engagements. \nThe NRC-HHT Research Centre works hand in hand with industry to help biotech firms achieve success. As an R&D partner of choice\, the NRC-HHT Research Centre de‑risks critical steps in the development of biologics\, vaccines\, and delivery of large molecules to the brain\, to help improve the health of Canadians. NRC-HHT adds value to collaborators’ products and accelerates their progress to market by overcoming challenges in preclinical development and product characterization\, optimizing bioprocesses and their scale-up\, and developing biomarkers. \nSuccess stories were presented on the co-development model used by Canadian biotechs that have partnered with NRC to accelerate their innovative biologic products development and the new assets in development. \n  \nEvent Schedule: \n9:00am –  Intro Presentation from LSBC: Dr. Lesley Esford\, President & CEO\, LSBC\nIntro from NRC: Eileen Raymond\, Business Advisor\, Business Management Support unit\, NRC \n9:15am – ‘NRC Advanced Biologics and Biomanufacturing Program’ \nPresenter: Dr. Lynne LeSauteur\, R&D Director\, Downstream Processing and Analytics\, and Program Leader\, Biologics and Biomanufacturing\, NRC \nNRC is seeking new opportunities for co-development of biologics for cancer and CNS diseases\, vaccines for unmet needs and enabling technologies \n9:35am – ‘NRC Genomics Expertise and Deep Learning Approaches’ \nPresenter: Dr. Simon Drouin\, Team Leader\, Applied Genomics\, NRC \nNRC is seeking to leverage their applied genomics expertise and capacities for gene- and cell-based therapy development \n9:45am – Questions and Networking break  \n10:15am – NRC Health Challenge Program: \n‘Transforming Health Outcomes through Engineered Cell and Gene Therapies’ \nPresenter: Dr. Danica Stanimirovic\, Director of Translational Bioscience Department and Interim Program Director\, NRC Health Challenge Program \nNRC is seeking to engage discussions on the collaborative opportunities for this program focussing on disruptive technologies applied to next generation of engineered cell and gene therapies \n10:45am – Open discussion and Networking \n11:30am – End of session
URL:https://lifesciencesbc.ca/event/nrcs-human-health-therapeutics-programs-recharge/
CATEGORIES:2018
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181114
DTEND;VALUE=DATE:20181115
DTSTAMP:20260404T110632
CREATED:20181114T080013Z
LAST-MODIFIED:20210902T233923Z
UID:635-1542153600-1542239999@lifesciencesbc.ca
SUMMARY:2018 Canada Gairdner Public Lecture Series
DESCRIPTION:On Wednesday\, November 14\, 2018\, LifeSciences BC partnered with the Gairdner Foundation and Science World to present: \n‘2018 Canada Gairdner Public Lecture Series: Vancouver presented by TELUS Health’\n  \nThe event consisted of a public lecture and an interactive exhibitor display showcasing the best of the life sciences industry in British Columbia. \nPublic Lecture: ‘Precision Medicine – How science is changing the future of healthcare’\n\n\n\n\nSpeakers:\n\n\n\n\nDr. Janet Rossant \nPresident & Scientific Director\nGairdner Foundation &\nChief of Research Emeritus\nSickKids Research Institute\n\n\n\nDr. Victor Dzau \nPresident\nNational Academy of Medicine \n\n\n\n\n\n\n 
URL:https://lifesciencesbc.ca/event/2018-canada-gairdner-public-lecture-series/
LOCATION:Science World\, Canada
CATEGORIES:2018
ATTACH;FMTTYPE=image/png:https://lifesciencesbc.ca/wp-content/uploads/2018/11/gairdner2018.png
ORGANIZER;CN="Life Sciences BC":MAILTO:events@lifesciencesbc.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181108
DTEND;VALUE=DATE:20181109
DTSTAMP:20260404T110632
CREATED:20180208T080022Z
LAST-MODIFIED:20210914T164251Z
UID:641-1541635200-1541721599@lifesciencesbc.ca
SUMMARY:McCarthy Spotlight Speaking Series: The Science of Communication
DESCRIPTION:On Thursday\, November 8\, 2018\, LifeSciences BC held the fall McCarthy Spotlight Speaking Event. \nEvent Topic: The Science of Communication \nSpeakers: \n\nMegan Helmer\, President\, PR Associates\nWilliam Johnson\, Director\, Marketing & Communications\, Innovate BC\nMichelle Sklar\, Director of Conferences\, Cube Business Media\nAlexandra Weirich\, Communications Lead\, AbCellera\n\nTrust in businesses\, government and the media are rapidly declining. Because trust impacts reputation\, it has become even more important now to present information clearly\, making it meaningful and well-understood. Effectively delivered communication will build trust and credibility and inform good decision-making. \nThere are multiple ways available to communicate\, but understanding the audience\, choosing an appropriate communication channel and moulding your message for each audience and channel is vital for effective communication. \nThis session began with a 30-minute presentation by Megan Helmer\, President of PR Associates\, focused on: \n\nThe what and why of effective communication\nAudience analysis and audience-centered communication\nBarriers to effective communication and how to overcome them\nHow to incorporate storytelling\n\nA panel of the life sciences industry’s top communication professionals then discussed additional communication recommendations and the light of their professional experiences. \nOur McCarthy Spotlight Speaking Series is one of our longest-standing event series – and one in which our attendees see the most value. Held twice a year\, these events start with presentations on specific topics by local representatives of LifeSciences BC members. Typically\, the event is attended by a cross-section of approximately 40 of our life sciences community members representing mainly industry\, NPOs\, and Government. \n \nIn the past\, the series has featured topics focusing on attracting and keeping good talent\, technology and licensing\, M&A and Capital Markets\, to name a few.
URL:https://lifesciencesbc.ca/event/mccarthy-spotlight-speaking-series-the-science-of-communication/
LOCATION:McCarthy Vancouver offices\, 2400 - 745 Thurlow St\, Vancouver\, BC\, Canada
CATEGORIES:2018
ATTACH;FMTTYPE=image/jpeg:https://lifesciencesbc.ca/wp-content/uploads/2021/02/mccarthy-spotlight.jpg
ORGANIZER;CN="Life Sciences BC":MAILTO:events@lifesciencesbc.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181101
DTEND;VALUE=DATE:20181102
DTSTAMP:20260404T110632
CREATED:20210407T185059Z
LAST-MODIFIED:20210914T164020Z
UID:24246-1541030400-1541116799@lifesciencesbc.ca
SUMMARY:LifeSciences BC Workshop: How to be Investor Ready
DESCRIPTION:On Thursday\, November 1\, 2018\, LifeSciencesBC held the “LifeSciences BC Workshop: How to be Investor Ready” event. \nAre you ready to take your company to the next level? Attract investor attention by ensuring your company is set up for success. \nAt this workshop\, Gowling WLG professionals and clients provided key information\, tips and real-world examples of how your company can prepare to successfully raise capital\, including: \n\nConducting intellectual property due diligence\nSetting up your share structures and shareholder agreements\nDetermining a company’s value\nGoing public\n\nSpeakers: \n\nKyle Araki\, Director\, TSX Venture Exchange\nPeter Fairey\, Partner\, Gowling WLG\nDoug Janzen\, Chairman & CEO\, Aequus Pharmaceuticals\nBrian Kingwell\, Partner\, Gowling WLG\nChris Nobes\, Managing Director\, Duff & Phelps\nDenis Silva\, Partner\, Gowling WLG\nDr. Kaley Wilson\, Director\, Business Development\, Quark Ventures\n\nEvent Schedule: \n9:30am – Registration (coffee and pastries provided) \n10:00am – Panel 1: Intellectual Property & Due Diligence – Brian Kingwell\, Partner\, Gowling WLG; and Kaley Wilson\, Director of Business Development\, Quark Ventures \n10:30am – Panel 2: Share Structures\, Shareholder Agreements & Valuations – Peter Fairey\, Partner\, Gowling WLG; and Chris Nobes\, Managing Director\, Duff & Phelps \n11:00am – Panel 3 (fireside chat format): Going Public – Denis Silva\, Partner\, Gowling WLG; Doug Janzen\, CEO\, Aequus Pharmaceuticals; and Andrew Creech\, Director\, TSX Venture Exchange \n12:00pm – Networking Lunch
URL:https://lifesciencesbc.ca/event/lifesciences-bc-workshop-how-to-be-investor-ready/
CATEGORIES:2018
ATTACH;FMTTYPE=image/png:https://lifesciencesbc.ca/wp-content/uploads/2021/04/gowling2018.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181025
DTEND;VALUE=DATE:20181026
DTSTAMP:20260404T110632
CREATED:20181025T070046Z
LAST-MODIFIED:20210902T231039Z
UID:646-1540425600-1540511999@lifesciencesbc.ca
SUMMARY:LifeSciences BC Investor Summit 2018 presented by Lumira Ventures
DESCRIPTION:On Thursday\, October 25\, 2018\, LifeSciences BC and Lumira Ventures were proud to partner in presenting the Investor Summit 2018 held in Vancouver at the Fairmont Pacific Rim. The Investor Summit brought together stakeholders in the healthcare innovation ecosystem for an exciting day of company pitches\, panel discussions and a keynote address. Entrepreneurs told their stories and got feedback and engagement from a wide range of investor stakeholders including; angel investors\, venture capital\, corporate ventures and funding foundations. \n\n  \nKeynote Speaker:  \nKarimah Es Sabar\, CEO & Partner\, Quark Ventures &\nChair\, Health and Biosciences Economic Strategy Table \n\n \nPresenting Companies: \nAgilik\, Augurex\, Biointeractive Technologies Inc.\, Conquer Experience\, Eupraxia\, GenomeMe Lab Inc.\, LightIntegra Technology Inc.\, MedGenesis Therapeutix Inc.\, Naegis Pharmaceuticals Inc.\, NZ Technologies Inc.\, Pacylex Pharmaceuticals Inc.\, Primary Peptides Inc.\, Qu Biologics\, Sonic Incytes Medical Corp.\, Tentarix Biologics Ltd.\, Tevosol\, Vesalius Cardiovascular Inc.\, XCO\, Zucara Therapeutics Inc.\n\n\n  \nMorning Presentation:  \n‘The Digital Age: Getting Digital Health Startups to Commercialization’ \nDr. Allan Miranda\, Head\, JLabs Canada \n\n\n\n\nLunchtime Panel: \n\nChair: Cheryl Reicin\, Partner\, Torys \nDaniel Hetu\, Managing Director\, Lumira Ventures \nJames Taylor\, CEO & Co-Founder\, Precision Nanosystems \nPraveen Gupta\, President & CEO\, PHEMI \nSacha Mann\, Advisor \nAfternoon Presentation: \n‘Towards Regulating Advanced Technology Health Products’ \nDavid Lee\, Chief Regulatory Officer\, Health Canada \nAfternoon Panel: \nChair: Andrew Casey\, President & CEO\, BIOTECanada \nNorma Blin\, CEO & Co-Founder\, Augurex \nJennifer Chan\, Vice-President\, Merck Canada \nKarimah Es Sabar\, CEO & Partner\, Quark Ventures & \nChair\, Health and Biosciences Economic Strategy Table \n  \nRead more about the Investor Summit here.\n \nClick here for the Investor Summit Agenda \n \nClick here for the Investor Summit Program \n  \n  \n  \n  \n  \n  \n  \n  \n  \n  \n  \n  \n  \n  \n  \n  \n  \n  \n \n\n\n\n 
URL:https://lifesciencesbc.ca/event/2018-lsbc-investor-summit-and-health-bioscience-economic-tables-report/
LOCATION:Fairmont Pacific Rim\, 1038 Canada Pl\, Vancouver\, BC\, V6C 0B9\, Canada
CATEGORIES:2018
ATTACH;FMTTYPE=image/png:https://lifesciencesbc.ca/wp-content/uploads/2018/10/investor2018.png
ORGANIZER;CN="Life Sciences BC":MAILTO:events@lifesciencesbc.ca
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181017
DTEND;VALUE=DATE:20181018
DTSTAMP:20260404T110632
CREATED:20210407T185452Z
LAST-MODIFIED:20210902T230522Z
UID:24252-1539734400-1539820799@lifesciencesbc.ca
SUMMARY:LifeSciences BC Showcase Series: Prince George
DESCRIPTION:On Wednesday\, October 17\, 2018\, LifeSciences BC presented a unique opportunity to learn more about LifeSciences BC along with the cutting-edge research and development being done in the Prince George area. The event was a networking opportunity for a wide range of guests from the political\, business and academic worlds. \n  \n\n\n\n\nSpeakers:\n\n\n\n\n\nDr. Lesley Esford \nPresident & CEO\nLifeSciences BC \n\n\n\n\n\nDr. David Llewellyn \nSenior Vice President of Business Operations\nSTEMCELL Technologies \n\n\n\n\n\nDr. Geoff Payne \nVice President of Research and Graduate Programs\nUNBC \nBoard Director\nMichael Smith Foundation for Health Research \n\n\n\n\n\nDr. Luke Harris \nAssociate Professor\, School of Health Sciences\nUNBC \n\n\n\n\n\n  \n\n\n\n\nSpeaker sponsor:\n\n\nEvent sponsor:\n\n\nEvent supporter:\n\n\n\n\n\n\n\n  \n\n  \n\n 
URL:https://lifesciencesbc.ca/event/lifesciences-bc-showcase-series-prince-george-2/
CATEGORIES:2018
ATTACH;FMTTYPE=image/png:https://lifesciencesbc.ca/wp-content/uploads/2021/04/princeggeorge2018.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180927
DTEND;VALUE=DATE:20180928
DTSTAMP:20260404T110632
CREATED:20210407T185635Z
LAST-MODIFIED:20210914T163928Z
UID:24255-1538006400-1538092799@lifesciencesbc.ca
SUMMARY:LifeSciences BC Blakes Breakfast Speaking Event
DESCRIPTION:This Breakfast Speaking Series is proudly presented by: \n \nLifeSciences BC was pleased to announce the Blakes Breakfast Speaking Event for Thursday\, September 27\, 2018. \nThe Blakes Breakfast Speaking Series is our longest-standing event series and one of our most popular. Held four times a year\, these breakfasts include presentations by local\, national and multinational life science companies and typically attract a cross-section of approximately 60 of our life sciences community members. The Breakfast Speaking Series is proudly presented by Blake\, Cassels & Graydon LLP. \n  \nKeynote Presentation: “Pfizer’s Innovation Ecosystem – Breakthrough Impact for Patients” \nDr. Arpita Maiti\, Senior Director\, External Science & Innovation (ES&I)\, Inflammation & Immunology and Microbiome at Pfizer Boston \nPfizer engages in flexible partnership models that include research collaborations\, venture capital investments\, academic alliances for drug development\, early-stage seed funding\, establishing incubators\, licensing\, and spinning out of companies. Their externally-focused scientific team of high-profile PhDs/MDs\, embedded within their research groups – identifies late-breaking science that forms the basis of innovative therapies and drives collaborations that are aimed at delivering value to Pfizer\, their partners\, and patients. \nDr. Arpita Maiti joined us to discuss Pfizer’s partnering models and their breakthrough impact for patients. \n  \nSpeakers: \nTamer Mohamed\, CEO at Aspect Biosystems \nDr. Michael Gallo\, President of Innovative Targeting Solutions
URL:https://lifesciencesbc.ca/event/lifesciences-bc-blakes-breakfast-speaking-event-3/
CATEGORIES:2018
ATTACH;FMTTYPE=image/png:https://lifesciencesbc.ca/wp-content/uploads/2021/04/blakessep272018.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180925
DTEND;VALUE=DATE:20180926
DTSTAMP:20260404T110632
CREATED:20210407T190315Z
LAST-MODIFIED:20210914T163853Z
UID:24258-1537833600-1537919999@lifesciencesbc.ca
SUMMARY:LifeSciences BC Annual General Meeting 2018
DESCRIPTION:On Tuesday\, September 25\, 2018\, LifeSciences BC invited members and sponsors to attend LifeSciences BC’s 2018 Annual General Meeting. The meeting reviewed the past fiscal year and previewed plans for the current fiscal year. A continental breakfast was served\, sponsored by RBC.   \nEvent supporter:
URL:https://lifesciencesbc.ca/event/lifesciences-bc-annual-general-meeting-2018/
CATEGORIES:2018
ATTACH;FMTTYPE=image/jpeg:https://lifesciencesbc.ca/wp-content/uploads/2021/04/lsbcagm2018.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180620
DTEND;VALUE=DATE:20180621
DTSTAMP:20260404T110632
CREATED:20210407T194034Z
LAST-MODIFIED:20210903T212124Z
UID:24267-1529452800-1529539199@lifesciencesbc.ca
SUMMARY:22nd Annual LifeSciences BC Salmon BBQ
DESCRIPTION:On Wednesday\, June 20\, 2018\, LifeSciences BC held the 22nd Annual LifeSciences BC Salmon Barbecue. \nThe Annual LifeSciences BC Salmon BBQ has become one of LSBC’s most popular events of the year. \nWith over 20 years of history\, this social evening and special celebration event offered our life sciences community the opportunity to enjoy a great meal in the company of 100+ peers in a breathtaking setting.
URL:https://lifesciencesbc.ca/event/22nd-annual-lifesciences-bc-salmon-bbq/
CATEGORIES:2018
ATTACH;FMTTYPE=image/jpeg:https://lifesciencesbc.ca/wp-content/uploads/2021/04/salmonbbq2018.jpeg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180605
DTEND;VALUE=DATE:20180606
DTSTAMP:20260404T110632
CREATED:20210407T215322Z
LAST-MODIFIED:20210902T223448Z
UID:24270-1528156800-1528243199@lifesciencesbc.ca
SUMMARY:Canadian panel on talent at BIO Boston presented by Pfizer
DESCRIPTION:On Tuesday\, June 5\, 2018\, LifeSciences BC held a Canadian panel on talent at BIO Boston\, presented by Pfizer. Talent will be one of the biggest constraints that Canadian life sciences companies will face. The panel explored strategies for attracting\, retaining and training the executive leaders needed to build global life science companies. \nEmcee: Dr. Lesley Esford\, President & CEO\, LifeSciences BC \nModerator: Cedric Bisson\, Partner\, Teralys Capital \nThe Panel: \n\nGordon McCauley\, President & CEO\, The Centre for Drug Research and Development\nMel Wong\, President & CEO\, Bio Alberta\nParimal Nathwani\, Vice President\, MaRS Innovation\nMichelle Savoie\, CEO\, Consilio Manuque\nKarimah Es Sabar\, CEO & Partner\, Quark Venture Inc & Director\, Global Health Sciences Fund\n\nPresenting sponsor: Pfizer \nEvent sponsor: BioTalent Canada
URL:https://lifesciencesbc.ca/event/canadian-panel-on-talent-at-bio-boston-presented-by-pfizer/
CATEGORIES:2018
ATTACH;FMTTYPE=image/jpeg:https://lifesciencesbc.ca/wp-content/uploads/2021/04/bioboston2018.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180604
DTEND;VALUE=DATE:20180605
DTSTAMP:20260404T110632
CREATED:20210407T215544Z
LAST-MODIFIED:20210902T223151Z
UID:24282-1528070400-1528156799@lifesciencesbc.ca
SUMMARY:LifeSciences BC BIO Reception & Dinner 2018 presented by FARRIS
DESCRIPTION:  \n \nOn Monday\, June 4\, 2018\, LifeSciences BC held its annual BC BIO Dinner\, presented by FARRIS\, in Boston. \nOver 100 senior life sciences executives from British Columbia\, as well as international delegates from around the world\, came together at this networking reception and dinner event in Boston as part of the 2018 BIO International Convention. \nInvitations to LifeSciences BC members attending the 2018 BIO International Convention were sent in early May 2018 \nBackgrounder: \nThe BIO International Convention is the largest global event for the biotechnology industry and attracts the biggest names in biotech\, offers key networking and partnering opportunities and provides insights and inspiration on the major trends affecting the industry. The event features keynotes and sessions from key policymakers\, scientists\, CEOs and celebrities. Past speakers include Presidents George W. Bush and Bill Clinton\, Former Prime Minister Tony Blair\, Michael J. Fox\, Sir Elton John\, Her Majesty Queen Noor of Jordan and General Colin Powell. The Convention also features the BIO Business Forum (One-on-One Partnering)\, hundreds of sessions covering biotech trends\, policy issues and technological innovations\, and the world’s largest biotechnology exhibition – the BIO Exhibition.\n________________________________________________________________________ \nEvent supporter: \n 
URL:https://lifesciencesbc.ca/event/lifesciences-bc-bio-reception-dinner-2018-presented-by-farris/
CATEGORIES:2018
ATTACH;FMTTYPE=image/jpeg:https://lifesciencesbc.ca/wp-content/uploads/2021/04/farris2018.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180527
DTEND;VALUE=DATE:20180528
DTSTAMP:20260404T110632
CREATED:20210407T215912Z
LAST-MODIFIED:20210902T222855Z
UID:24285-1527379200-1527465599@lifesciencesbc.ca
SUMMARY:2018 Microsemi Science Fair Fun Run
DESCRIPTION:  \nOn Sunday\, May 27\, 2018\, the Microsemi Science Fair Fun Run took place. The Annual Science Fair Fun Run is the largest timed 5k fun run in the province\, one of the largest fundraising events in BC’s technology sector\, and a major event in Vancouver. \nYour participation in the Annual Microsemi Science Fair Fun Run ensures the success of future Science Fairs in BC and allows our youth to gain the skills they need to succeed in a fast-paced\, knowledge-based world. \nWebsite: http://www.sciencefairs.ca/fun-run/ \nIf you are interested in signing up your corporate team\, please contact: \nIrma Zukic\nLifeSciences BC\n604-669-9909 ext 1\nizukic@lifesciencesbc.ca \nFor all other inquiries related to the Microsemi Science Fair Fun Run\, please contact: \nMadeleine Guenette\nDirector of Operations\n604-602-5219\nmguenette@sciencefairfoundationbc.ca \nMailing Address:\nScience Fair Foundation of BC\n900 – 1188 West Georgia St.\nVancouver\, BC\nV6E 4A2
URL:https://lifesciencesbc.ca/event/2018-microsemi-science-fair-fun-run/
CATEGORIES:2018
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180524
DTEND;VALUE=DATE:20180525
DTSTAMP:20260404T110632
CREATED:20210407T220438Z
LAST-MODIFIED:20210914T163801Z
UID:24289-1527120000-1527206399@lifesciencesbc.ca
SUMMARY:LifeSciences BC Blakes Breakfast Speaking Event
DESCRIPTION:This Breakfast Speaking Series is proudly presented by: \n \nEvent sponsor: \n \nOn Thursday\, May 24\, 2018\, LifeSciences BC held its Blakes Breakfast Speaking Event. \nThe Blakes Breakfast Speaking Series is our longest-standing event series and one of our most popular. Held four times a year\, these breakfasts include presentations by local\, national and multinational life science companies and typically attract a cross-section of approximately 40 of our life sciences community members. The Breakfast Speaking Series is proudly presented by Blake\, Cassels & Graydon LLP. \nTheme: Models to Advance Innovation \nKeynote speaker: \nDr. Allan F. Miranda\, Head of JLABS @ Canada \nSpeakers: \nDr. Carl Hansen\, CEO & President of AbCellera \nDr. Ali Tehrani\, CEO & President of Zymeworks
URL:https://lifesciencesbc.ca/event/lifesciences-bc-blakes-breakfast-speaking-event-4/
LOCATION:Terminal City Club\, Vancouver\, Canada
CATEGORIES:2018
ATTACH;FMTTYPE=image/jpeg:https://lifesciencesbc.ca/wp-content/uploads/2021/04/blakesmay242018.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180524
DTEND;VALUE=DATE:20180525
DTSTAMP:20260404T110632
CREATED:20210407T220125Z
LAST-MODIFIED:20210902T211210Z
UID:24287-1527120000-1527206399@lifesciencesbc.ca
SUMMARY:NRC Event: Reimbursement in Europe Workshop
DESCRIPTION:On Thursday\, May 24\, 2018\, LifeSciences BC held its NRC Event: Reimbursement in Europe Workshop. \nWhy Europe? \nEurope represents a highly attractive market for Canadian medical technology manufacturers. With over 500 million people in 28 countries in the European Union alone\, now is the time to take advantage of transparent and reliable reimbursement conditions at the federal level. \nWhy Should You Join?  \nAll European countries have very different reimbursement environments\, health care practices\, sales and distribution options. Choosing the countries that best suit your company and products for initial launch and future sales is crucial as incorrect steps are costly. This interactive full-day workshop was designed to help you understand the various reimbursement schemes in the largest European markets and about first steps towards cost-effective operations in this regard. This seminar focused on Germany and provide additional information on the UK\, France\, Italy and Sweden. \nWho Should Join?  \nCEOs\, CFOs\, VPs Marketing\, Export Managers\, etc.\, who plan to enter the European market or who want some ideas on maximizing sales. \nThe Speaker: \nMichael Weisser\, a research consultant with Assessment in Medicine (AiM GmbH)\, Germany was invited to give you the best know-how to decide which countries are most suited for your business.
URL:https://lifesciencesbc.ca/event/nrc-event-reimbursement-in-europe-workshop/
CATEGORIES:2018
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180523
DTEND;VALUE=DATE:20180524
DTSTAMP:20260404T110632
CREATED:20210407T220553Z
LAST-MODIFIED:20210902T210817Z
UID:24292-1527033600-1527119999@lifesciencesbc.ca
SUMMARY:4th Annual Medical Device Playbook
DESCRIPTION: \n\n\n\nMedical Device Playbook is Canada’s premiere event for medical device professionals. The 4th annual Playbook returned to the Vancouver Terminal City Club on Wednesday\, May 23\, 2018. \nIndustry speakers and panels from British Columbia and across North America discussed what it took to achieve the 2018 theme: Dream a Bigger Dream. \nThis event presented an opportunity to network and learn 2018 trends\, opportunities\, and strategies. Attendees heard Medtech Entrepreneur Case Studies\, Human Factors Insights\, and Clinical/Regulatory advice from industry veterans including: \n\nSTAN LAPIDUS\, Director of numerous public and private medical device and diagnostics companies – Denver\, Founded and led two of the most successful (>$2Bn value) diagnostics companies of all time\nMITCH LEVINSON\, Co-Founder\, President and CEO at Cerebrotech – San Francisco\, CEO/CSO of Coolsculpting system and device\nVIRGINIA A. LANG\, President and Chief Scientist\, HirLan\, Inc. and HirLan International SA – Carlsbad CA\, Human Factors Pioneer\nMIKE TOTTERMAN\, CEO and co-founder of Clerio Vision – Rochester NY\, Co-founded iCardiac Technologies\, and VirtualScopics; former principal at 3Com Ventures\nKEVIN STRANGE\, President and CEO at Biolux Research\, 20 Year veteran of Vancouver Medical Device Start-ups\nMICHAEL HOEY\, Co-Founder & Chief Technology Officer\, NxThera – Minneapolis\, Expert in thermotherapy with 72 patents granted and 94 patents pending \nPAUL WEBER\, President and Chief Executive Officer Perimeter Medical Imaging – Toronto\, Medical Device Marketing\, International Distribution\, and Business Development Expert\nDOUG GOERTZEN\, CEO\, Kardium – Vancouver\, Local SFU EE grad now leading Medtech start-up\nVESNA JANIC\, Director of QA/RA StarFish Medical – Victoria\, QA/RA expert responsible for 30+ concurrent medical devices and client companies\nSCOTT PHILLIPS\, CEO\, StarFish Medical – Victoria\, Creator Medical Device Playbook\nDR. LESLEY ESFORD\, President & CEO\, LifeSciences British Columbia – Vancouver\, Academia\, industry and government leader supporting the growth of the Life Sciences sector\nCHRIS MACDONALD\, Sales Manager\, Canada MHS Business Line\,   TÜV SÜD Canada – Toronto\, Global regulatory compliance expert\nELAYNE WANDLER\, Director\, Programs & Partnerships Accel-Rx – Vancouver\, Health sciences executive and Entrepreneur\nJAMES JACKSON\, Industrial Designer\, StarFish Medical – Victoria\, Designed category-leading products for Logitech\, Olympus\, Medtronic\, Welch Allyn\, Covidien\, and Hollister\n\n\nThis event included Lunch\, Breaks\, and a Networking Reception.\n\n\n\n\n\n\nAGENDA\n\n\n08:00 – 8:50\n\nRegistration\, Coffee/Tea & Networking \n\n08:50 – 9:00\n\nWelcome & Opening Remarks \nSCOTT PHILLIPS\, CEO\, StarFish Medical \n\n9:00 – 10:45\n\nEntrepreneur Presentations \nDOUG GOERTZEN: Kardium – The journey of transforming a naïve idea into a commercial medical device \nSTAN LAPIDUS: Asking Better Questions – how asking new questions leads to the development of large businesses. \nKEVIN STRANGE: My 20 years of Medical Device Start-ups in Vancouver \n\n10:45 – 11:15\n\nCoffee/Tea & Networking \n\n11:15 – 12:30\n\nDesigning Your Company \nMITCH LEVINSON: Cerebrotech: A company “designed” to survive an unforgiving financing environment \nMICHAEL HOEY: Are you limiting your platform’s potential? \n\n12:30 – 13:15\n\nLunch \n\n13:15 – 13:30\n\nAfternoon Welcome & Opening Remarks \nDR.LESLEY ESFORD\, President & CEO\, LifeSciences British Columbia \n\n13:30 – 14:30\n\nPartnering \nMIKE TOTTERMAN: Strategic Partnering to Support Medical Device Development \nPAUL WEBER: Doing strategic partner deals \n\n14:30 – 15:00\n\nHuman Factors \nVIRGINIA A. LANG: Human Factors is good business — not an obstacle! \n\n15:00 – 15:30\n\nCoffee/Tea & Networking \n\n15:30 – 16:30\n\nClinical/Regulatory \nVESNA JANIC: Preparing for ISO 13485:2016 \nCHRIS MACDONALD: Do’s and Don’ts of Medical Electrical device certification and testing \nJAMES JACKSON: Are you designing for the correct guidance regulations? \n\n16:30 – 16:50\n\nChanging Perspectives \nSCOTT PHILLIPS: Dream a Bigger Dream \n\n16:50 – 17:00\n\nClosing Remarks \nSCOTT PHILLIPS: Closing Remarks \n\n17:00 – 18:00\n\nNetworking Reception \nELAYNE WANDLER: Reception Welcome \nReception sponsored by Accel-Rx Health Sciences Accelerator \n\n\n\n\nAll net proceeds went to LifeSciences BC for future MedTech initiatives.
URL:https://lifesciencesbc.ca/event/4th-annual-medical-device-playbook/
CATEGORIES:2018
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180510
DTEND;VALUE=DATE:20180511
DTSTAMP:20260404T110632
CREATED:20210407T220728Z
LAST-MODIFIED:20211018T225401Z
UID:24294-1525910400-1525996799@lifesciencesbc.ca
SUMMARY:IP Protection for the Cannabis Industry
DESCRIPTION:Using IP to Protect Medical Applications of Cannabis:  Tips and Strategies for Innovators\nWith the impending legalization of recreational cannabis\, there is tremendous interest in a plant that has long lurked in the shadows of illegality. There is also significant interest in the medicinal qualities of cannabis and some of its key components\, which are useful in managing chronic pain and show promise in the treatment of numerous disorders.  With such unexplored ground comes the potential to develop new innovations\, and a need to protect those innovations in the best way possible. \nThere are a number of ways that intellectual property (IP) can be used to protect cannabis-related innovations. On Thursday\, May 10\, 2018\, LifeSciences BC held its IP Protection for the Cannabis Industry session\, which outlined how IP can be applied to help businesses secure the value of new innovations relating to medical applications of cannabis. Specific examples of medical applications of cannabis or cannabinoids that have been patented or are the subject of pending patent applications were given and compared to contrasting examples of situations where trade secret protection might be considered over patent protection. Different strategies for protecting new strains of cannabis were discussed\, as well as the interplay between plant breeders’ rights and trademark rights when the names of new strains are to be protected. \nThis session was of interest to those concerned with IP strategy for companies investigating new medical applications of cannabis or new cannabis strains\, as well as to investors looking to ensure that their investments in this sector will be protected. This session also offered those who are interested in the cannabis industry generally an opportunity to learn more about some of the unique considerations that apply to using IP to protect cannabis-related innovations. \nSpeakers:\nJennifer Marles: partner and intellectual property lawyer with Oyen Wiggs \nGina Lupino: registered US Patent Attorney \n\nLana Culley: Director of Business Development\, Anandia Labs \n\nEvent sponsor:
URL:https://lifesciencesbc.ca/event/ip-protection-for-the-cannabis-industry/
CATEGORIES:2018
ATTACH;FMTTYPE=image/jpeg:https://lifesciencesbc.ca/wp-content/uploads/2021/04/ipprotection2018.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180508
DTEND;VALUE=DATE:20180509
DTSTAMP:20260404T110632
CREATED:20210407T220858Z
LAST-MODIFIED:20210902T205422Z
UID:24296-1525737600-1525823999@lifesciencesbc.ca
SUMMARY:MedTech Showcase Series: Clarius Mobile Health
DESCRIPTION:On Tuesday\, May 8\, 2018\, LifeSciences BC held its Medtech Showcase Series: Clarius Mobile Health event. Founded by ultrasound innovators\, Clarius Mobile Health aims to make ultrasound available to all clinicians. Clarius Mobile’s high-resolution\, affordable handheld ultrasound scanners offer clinicians the freedom to use ultrasound anywhere they need it. Clarius Scanners are regulatory cleared for sale in more than 20 countries worldwide. For more information\, visit www.clarius.com. \nSpeakers:  \nLaurent Pelissier\, CEO\, Clarius Mobile Health \nKris Dickie\, VP of R&D\, Clarius Mobile Health
URL:https://lifesciencesbc.ca/event/medtech-showcase-series-clarius-mobile-health/
CATEGORIES:2018
ATTACH;FMTTYPE=image/jpeg:https://lifesciencesbc.ca/wp-content/uploads/2021/04/medtech2018.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180419
DTEND;VALUE=DATE:20180420
DTSTAMP:20260404T110632
CREATED:20210407T221717Z
LAST-MODIFIED:20210927T190050Z
UID:24300-1524096000-1524182399@lifesciencesbc.ca
SUMMARY:20th Annual LifeSciences BC Awards Dinner\, presented by FARRIS
DESCRIPTION:20th Annual LifeSciences BC Awards\npresented by\n\nThursday\, April 19\, 2018\nFairmont Hotel Vancouver\nEvent Photos \nKEYNOTE ADDRESS\nHon. Bruce Ralston \nMinister\, Jobs\, Trade and Technology \nThe 2018 LifeSciences BC Award Winners\nGenome BC Award for Scientific Excellence \nDr. Sally Aitken\n\nMichael Smith Foundation for Health Research \nAubrey J. Tingle Award\nDr. David Huntsman\n\nMilton Wong Award for Leadership\nDr. Michael Abrams\n\nGrowth Stage Life Sciences Company of Year\nAbCellera Biologics Inc.\n\nStrategic Life Sciences Partner of the Year Award\nStarFish Medical Inc.\n\nMedtech Company of the Year\nRedlen Technologies Inc.\n\nGrowth Stage Medtech Company of the Year\nbioLytical Laboratories Inc.\n\nDeal of the Year Award\nZymeworks Inc.\n \nLifeSciences Company of the Year\nAurinia Pharmaceuticals Inc.\n\nDr. Don Rix Award for Lifetime Achievement\nDrs. Connie & Allen Eaves\nPresented by: \n  \nFarris LLP \n  \nAward Sponsors:  \n\n\n\n\n\n \n\n\n \n \n \n\n\n \n \n\n\n\n\nBook your one night stay at the Fairmont Hotel Vancouver! \n 
URL:https://lifesciencesbc.ca/event/20th-annual-lifesciences-bc-awards-dinner-presented-by-farris/
CATEGORIES:2018
ATTACH;FMTTYPE=image/jpeg:https://lifesciencesbc.ca/wp-content/uploads/2021/04/farrisawards2018.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20180328
DTEND;VALUE=DATE:20180329
DTSTAMP:20260404T110632
CREATED:20210407T222316Z
LAST-MODIFIED:20210902T204753Z
UID:24307-1522195200-1522281599@lifesciencesbc.ca
SUMMARY:MedTech Showcase Series: LightIntegra Technology
DESCRIPTION:LightIntegra’s first product\, ThromboLUX\, was introduced to the US market in late 2017 and is starting to make a splash – by using ThromboLUX to determine platelet activation status\, hospitals are seeing unprecedented reductions in platelet use for blood cancer treatment. On Wednesday\, March 28\, 2018\, LifeSciences BC held its MedTech Showcase Series: LightIntegra Technology where attendees learned more about how ThromboLUX helps hospitals allocate platelets for more effective use\, and heard about its other applications in transfusion medicine and diagnostics.
URL:https://lifesciencesbc.ca/event/medtech-showcase-series-lightintegra-technology/
CATEGORIES:2018
ATTACH;FMTTYPE=image/jpeg:https://lifesciencesbc.ca/wp-content/uploads/2021/04/medtechlightintegra.jpg
END:VEVENT
END:VCALENDAR